| Followers | 144 |
| Posts | 27605 |
| Boards Moderated | 3 |
| Alias Born | 02/07/2004 |
Monday, April 27, 2020 9:09:47 AM
Apr. 27, 2020 8:50 AM ET|About: RedHill Biopharma Ltd. (RDHL)|By: Vandana Singh, SA News Editor
RedHill (NASDAQ:RDHL) jumps 13.9% in pre-market as Opaganib demonstrates measurable clinical improvement in all six moderate-to-severe COVID-19 patients treated.
Preliminary data show decreased requirement for supplemental oxygenation, higher lymphocyte counts and decreased CRP
Opaganib has been well tolerated and no patient required mechanical ventilation post the treatment with opaganib
IND had been submitted for a randomized clinical study in COVID-19 patients in the US, with clinical studies also planned in Israel and Italy.
https://seekingalpha.com/news/3564607-redhill-s-opaganib-under-compassionate-use-show-objective-clinical-improvement-shares-up-14?utm_medium=email&utm_source=seeking_alpha&mail_subject=rdhl-redhill-s-opaganib-under-compassionate-use-show-objective-clinical-improvement-shares-up-14-premarket&utm_campaign=rta-stock-news&utm_content=link-3
More exposure!
Recent RDHL News
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
